Independence from exogenous estrogen is unsurprising given the ER-negativity of SUM-225 cells, but an asset in the sense that slow-growing murine tumors of this nature may better represent indolent DCIS tumors than models requiring supplementation with supraphysiological estrogen levels. The gene discussed is ESR1; the disease is ductal breast carcinoma in situ.